These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 12182066

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Expression of protein p53: the marker of low neoplastic cell differentiation in thyroid carcinoma].
    Szybiński P, Nowak W, Stachura J, Nowak K, Przybylik-Mazurek E, Buziak-Bereza M.
    Wiad Lek; 2001; 54 Suppl 1():88-94. PubMed ID: 12182067
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma.
    Resnick MB, Schacter P, Finkelstein Y, Kellner Y, Cohen O.
    Mod Pathol; 1998 Aug; 11(8):735-9. PubMed ID: 9720501
    [Abstract] [Full Text] [Related]

  • 4. Expression of the GLUT1 glucose transporter, p63 and p53 in thyroid carcinomas.
    Kim YW, Do IG, Park YK.
    Pathol Res Pract; 2006 Aug; 202(11):759-65. PubMed ID: 17029809
    [Abstract] [Full Text] [Related]

  • 5. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV.
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [Abstract] [Full Text] [Related]

  • 6. Poorly differentiated follicular thyroid carcinoma with rhabdoid phenotype: a clinicopathologic, immunohistochemical and electron microscopic study of two cases.
    Albores-Saavedra J, Sharma S.
    Mod Pathol; 2001 Feb; 14(2):98-104. PubMed ID: 11235911
    [Abstract] [Full Text] [Related]

  • 7. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer.
    Wang S, Lloyd RV, Hutzler MJ, Safran MS, Patwardhan NA, Khan A.
    Mod Pathol; 2000 Aug; 13(8):882-7. PubMed ID: 10955455
    [Abstract] [Full Text] [Related]

  • 8. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
    Volante M, Landolfi S, Chiusa L, Palestini N, Motta M, Codegone A, Torchio B, Papotti MG.
    Cancer; 2004 Mar 01; 100(5):950-7. PubMed ID: 14983490
    [Abstract] [Full Text] [Related]

  • 9. c-Met expression in tall cell variant papillary carcinoma of the thyroid.
    Nardone HC, Ziober AF, LiVolsi VA, Mandel SJ, Baloch ZW, Weber RS, Mick R, Ziober BL.
    Cancer; 2003 Oct 01; 98(7):1386-93. PubMed ID: 14508824
    [Abstract] [Full Text] [Related]

  • 10. Mixed columnar cell and tall cell variant of papillary carcinoma of thyroid: a case report and review of the literature.
    Putti TC, Bhuiya TA.
    Pathology; 2000 Nov 01; 32(4):286-9. PubMed ID: 11186427
    [Abstract] [Full Text] [Related]

  • 11. Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland.
    Holm R, Nesland JM.
    J Pathol; 1994 Mar 01; 172(3):267-72. PubMed ID: 8195930
    [Abstract] [Full Text] [Related]

  • 12. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
    Savin S, Cvejic D, Isic T, Paunovic I, Tatic S, Havelka M.
    Hum Pathol; 2008 Nov 01; 39(11):1656-63. PubMed ID: 18657294
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM, Adabi Kh, Lashkari A, Heshmat R, Haghpanah V, Larijani B, Tavangar SM.
    Pathol Res Pract; 2009 Nov 01; 205(2):83-7. PubMed ID: 18996649
    [Abstract] [Full Text] [Related]

  • 14. Survivin expression is significantly linked to the dedifferentiation of thyroid carcinoma.
    Ito Y, Yoshida H, Uruno T, Nakano K, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Matsuura N, Kakudo K, Kuma K, Miyauchi A.
    Oncol Rep; 2003 Nov 01; 10(5):1337-40. PubMed ID: 12883703
    [Abstract] [Full Text] [Related]

  • 15. OCT4 expression on a case of poorly differentiated (insular) carcinoma of the thyroid gland and minireview.
    Ruangpratheep C, Lohachittranond C, Poonpracha T, Punyarit P.
    J Med Assoc Thai; 2005 Nov 01; 88 Suppl 3():S281-9. PubMed ID: 16858970
    [Abstract] [Full Text] [Related]

  • 16. Maspin in thyroid cancer: its relationship with p53 and clinical outcome.
    Boltze C, Schneider-Stock R, Meyer F, Peters B, Quednow C, Hoang-Vu C, Roessner A.
    Oncol Rep; 2003 Nov 01; 10(6):1783-7. PubMed ID: 14534696
    [Abstract] [Full Text] [Related]

  • 17. Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours.
    Wright PA, Lemoine NR, Goretzki PE, Wyllie FS, Bond J, Hughes C, Röher HD, Williams ED, Wynford-Thomas D.
    Oncogene; 1991 Sep 01; 6(9):1693-7. PubMed ID: 1923534
    [Abstract] [Full Text] [Related]

  • 18. Analysis of P53 and P21WAF1 proteins expression in follicular thyroid tumors.
    Ferenc T, Lewiński A, Lange D, Niewiadomska H, Sygut J, Sporny S, Jarzab B, Sałacińska-Loś E, Kulig A, Włoch J.
    Pol J Pathol; 2004 Sep 01; 55(4):133-41. PubMed ID: 15757200
    [Abstract] [Full Text] [Related]

  • 19. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
    Motti ML, Califano D, Baldassarre G, Celetti A, Merolla F, Forzati F, Napolitano M, Tavernise B, Fusco A, Viglietto G.
    Carcinogenesis; 2005 Jun 01; 26(6):1021-34. PubMed ID: 15718252
    [Abstract] [Full Text] [Related]

  • 20. Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions.
    Albores-Saavedra J, Hernandez M, Sanchez-Sosa S, Simpson K, Angeles A, Henson DE.
    Am J Surg Pathol; 2007 May 01; 31(5):729-36. PubMed ID: 17460457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.